Injective
INJ#75INJ is the coin of Injective, a proof-of-stake blockchain for trading apps, used to pay fees, secure the chain and fund token buybacks.
- Market cap
- $766.16M
- Volume 24h
- $71.82M
- All-time high
- $52.62
- −85.44% from ATH
- Circulating supply
- 100M
Does not clear all 8 Shariah criteria. Needs caution: nature of the asset, gambling (maysir), usage, and benefit and harm (maslahah). Fails: business model.
- 3 pass
- 4 caution
- 1 fail
Verdict history
- DoubtfulCurrent
First publication
Fundamentals, market picture and news will appear here.
Halal analysis
Can a Muslim hold Injective?8 Shariah criteria
3 pass · 4 caution · 1 failHolding INJ pays nothing; staking rewards are new INJ and fees paid for validating the network, with slashing live.
Riba means interest or any guaranteed increase on a loan. Simply holding INJ earns nothing. The native return is staking: validators earn newly minted INJ and part of transaction fees, and delegators receive a share minus the validator's commission. Issuance moves between 2.2% and 4.4% a year depending on how much INJ is staked; it was 4.4% on 27 September 2026, with about 47% of supply bonded. Staked INJ of validators and delegators can be slashed for misbehaviour, so the reward carries real risk and is tied to validation work, not a loan.
Interest does appear around INJ, for example in the Neptune Finance lending market on Injective, but that is judged under trading mechanisms, not as a feature of the coin. The Community BuyBack pays participants a share of fee revenue in exchange for INJ that is burned; this is a sale of INJ, not a loan, and its problems are discussed under business model.
Injective is a working network and INJ has clear uses, but official religious bodies disagree on whether cryptocurrency is property (mal).
Mal is property that Islamic law recognises as having value and that can be owned and traded. Injective has run a live mainnet since November 2021, and INJ is needed to pay fees, stake for consensus, vote on governance and take part in buyback-and-burn rounds. Malaysia's Securities Commission Shariah Advisory Council (2020), for assets under its supervision, treats digital currency without an underlying asset as goods ('urudh) that may be traded on registered exchanges.
Other tier-1 bodies disagree: Egypt's Dar al-Ifta (2017), the UAE General Authority of Islamic Affairs (2018), Turkey's Diyanet (2017) and Indonesia's MUI (2021) prohibit dealing in cryptocurrencies, and the OIC Fiqh Academy (2019) deferred a ruling. None of them names Injective. Because authoritative bodies disagree, this criterion cannot be 'pass'.
- Resolutions of the Shariah Advisory Council of the SC - Securities Commission Malaysia
- Ruling on trading and dealing in Bitcoin - Dar al-Ifta al-Misriyyah
- Kripto paraların kullanımının dini hükmü nedir? - Din İşleri Yüksek Kurulu (Diyanet)
- Keputusan Ijtima' Ulama Komisi Fatwa se-Indonesia VII tentang Hukum Cryptocurrency - Majelis Ulama Indonesia
INJ is not a gambling token, but in one-day snapshots trading around it and on its chain was dominated by leveraged perpetual futures, and the chain supports binary options markets.
Maysir is gambling: winning or losing by chance rather than through productive exchange. Ordinary price swings are not maysir, and INJ itself has no chance-based payout. The market around it is heavily speculative, though. On Binance on 27 September 2026, INJUSDT perpetual futures traded about $61 million over 24 hours against about $10.5–11 million on the spot pair, so futures were about 85% of that volume.
On the chain itself, Helix perpetuals traded about $67 million against about $18 million of spot DEX volume on the same day, so derivatives were roughly 79% of on-chain trading (single-day snapshots). Injective's exchange module also supports binary options markets, which pay all or nothing on an outcome and are close to betting. A real function exists alongside this: INJ secures and governs the network, and the chain hosts spot markets, tokenised assets and payments, so the asset is not built for gambling.
The protocol's distinctive income is trading fees from its own exchange module, which runs perpetuals, futures and binary options alongside spot; by design 60% of those fees go to buy back and burn INJ.
This criterion asks how the issuer or protocol earns, and whether any of that income is impermissible. Injective's distinctive revenue is exchange-module trading fees: 40% goes to the app that sourced the order and the remaining 60% is designated for an on-chain buy-back-and-burn. Under the original design that 60% is pooled into a basket auctioned for INJ, which is burned.
Injective says the monthly Community BuyBack, running since November 2025, evolved from and replaced that winner-take-all auction: participants commit INJ that is burned and receive a pro-rata share of ecosystem revenue (average earnings of about 23.9% over the first four rounds), but Injective does not break down where that revenue comes from. Injective's documentation shows the exchange module is built for derivative markets as well as spot: perpetual and expiry futures, binary options (all-or-nothing bets on a settlement price) and insurance funds to support higher-leverage derivative trading. Futures, perpetuals and options are impermissible. Injective does not publish the fee split between spot and derivatives; in a one-day snapshot on 27 September 2026 from secondary data (CoinGecko, DefiLlama), perpetuals were roughly 79% of on-chain trading volume. That share would have to fall more than fifteen-fold to drop below the 5% threshold, so the status is fail, but the exact share is an estimate. ShariaQuant reaches the same concern. Gas fees for ordinary transactions are service fees and are permissible.
Supply rules, burns and code are public and enforced on-chain, though aggregators misreport supply and governance can change key parameters.
Gharar is excessive uncertainty or hidden information in a deal. Injective's issuance rules are on-chain and public: inflation between 2.2% and 4.4% a year, adjusted toward a 60% staking goal, and burns through auctions and BuyBack rounds are recorded on-chain. The chain software is published on GitHub with tagged mainnet releases. On 27 September 2026 the on-chain supply was about 123.04 million INJ, while CoinGecko still showed 100 million, so holders relying on aggregators may be misinformed; the on-chain figure is the reference.
Residual concerns: the active validator set is capped at 45, and staked-INJ governance can change the auction, exchange and fee parameters that drive burns. Injective Labs and affiliated entities remain influential, but the rules are disclosed.
Derivatives trading is a large, possibly the largest, measured use of the chain, but that rests on one day of secondary data; spot, tokenisation and payments are real permissible uses.
This criterion looks at what the network is actually used for. Injective is designed around a built-in exchange whose documented market types include perpetual and expiry futures and binary options as well as spot. In a single-day snapshot on 27 September 2026 from secondary data, Helix perpetuals traded about $67 million over 24 hours against about $18 million of spot DEX volume on the chain, roughly 79% derivatives. Binary options markets and a lending market (Neptune Finance, about $1.8 million lent) add further impermissible uses, although both are small.
Permissible uses exist: spot markets (about $330 million of spot volume over 30 days), tokenised stocks (Stockdrop), mortgage data records for Pineapple Financial, stablecoin payments through Bitrefill and an SEC-registered transfer agent for tokenised securities; the newer ones were announced in August and September 2026 and their scale is not yet measured. The impermissible share of use is clearly large, but no primary or reputable source establishes that derivatives trading is the network's main purpose, so the status is caution at the bottom of its band rather than fail. The derivatives revenue itself is assessed under business model.
Fully paid spot INJ is available on major exchanges and can be held in one's own wallet.
This criterion asks whether the asset can be owned in a permissible way. INJ trades spot, with full payment and delivery, on major exchanges such as Binance, and it can be withdrawn to a self-custody wallet on Injective. In Europe, 21Shares offers an Injective exchange-traded product. Ownership therefore does not depend on derivatives or leveraged wrappers, even though derivatives dominate trading volume. How specific funds are structured is assessed separately under trading mechanisms.
Injective offers open financial infrastructure and new tokenisation uses, but its flagship use is leveraged derivatives trading open to retail users.
Maslahah weighs public benefit against harm. The benefit is real: an open, fast settlement layer with on-chain order books, cross-chain stablecoins and early tokenisation of stocks and mortgage data, plus an SEC-registered transfer agent for tokenised securities. The harm is also significant. The chain's flagship use is leveraged perpetual futures, which expose retail traders to liquidation losses, and binary options markets resemble betting.
Activity has also shrunk: Helix TVL fell from about $36 million in October 2024 to under $1 million in September 2026, and total DeFi TVL on the chain was about $14 million against a market value of about $783 million. Speculative trading losses are counted under maysir, not again here.
How you can use it
Tap a card for the ruling and sourcesBuying INJ with full payment and immediate delivery is available on major exchanges, and coins can be moved to a self-custody wallet. Spot is acceptable for a DOUBTFUL asset for those who follow the permissive view.
There is no approved US fund: Canary Capital's Staked INJ ETF, which would stake at least 90% of its INJ, was still pending. In Europe, 21Shares offers an Injective exchange-traded product; its terms, including any staking or lending of the underlying INJ, were not verified.
Tier-1 bodies such as Indonesia's MUI rule that using cryptocurrency as currency is not permissible, and paying with crypto is restricted in several countries. Payments on Injective, such as through Bitrefill, are mostly made in stablecoins rather than INJ.
Native staking, where you delegate INJ to a working validator, pays newly issued INJ and fees for validation work. You keep ownership, stake can be slashed for validator misbehaviour and unbonding takes 21 days, so the reward is not a guaranteed return. Liquid staking and exchange staking pool stake through an intermediary and should be checked product by product.
Margin trading in INJ is never acceptable: it is a deferred exchange with borrowed money and leverage (AAOIFI SS 20).
INJ perpetual futures dominate its trading volume, and Injective's own exchange module runs perpetuals, futures and binary options. Futures, perpetuals and options always fail under AAOIFI SS 20: deferred exchange without delivery, usually with leverage.
Lending INJ on platforms such as Neptune Finance, or through exchange lending programmes, pays depositors interest from borrowers. This is riba.
INJ yield products built on lending or leveraged strategies pay interest or interest-like returns and fail. Returns from the Community BuyBack are paid from ecosystem revenue that Injective does not break down and that likely includes fees from its derivatives markets, so they are not a clean alternative. Native staking is assessed separately above.
Scholars quotes
Penggunaan cryptocurrency sebagai mata uang hukumnya haram, karena mengandung gharar (ketidakjelasan), dharar (bahaya) dan bertentangan dengan Undang-Undang nomor 7 tahun 2011 tentang Mata Uang dan Peraturan Bank Indonesia nomor 17 tahun 2015 tentang Kewajiban Penggunaan Rupiah di Wilayah Negara Kesatuan Republik Indonesia.Sebagaimana mata wang yang lain, mata wang digital hendaklah tidak digunakan sebagai bayaran kepada barangan, perkhidmatan dan aktiviti tidak patuh Syariah seperti pembelian dadah, pelacuran, perjudian dan pendanaan aktiviti keganasan serta penggubahan wang haram.The SAC has also resolved that investment and trading of Digital Assets that fulfil the above requirements and which are traded on Digital Asset Exchange (DAX) registered with SC are permissible.Third: In light of the above and given the significant risks associated with this type of currencies and the instability of their transactions, the Council of the Academy recommends pursuing research and studies on issues affecting its ruling.Bitcoin is a digital currency that does not meet the legal and Sharia criteria that make it a currency subject to the rulings of dealing with official legal currencies recognized internationally.بناءً على ذلك: فلا يجوز شرعًا تداول عملة "البتكوين" والتعامل من خلالها بالبيعِ والشراءِ والإجارةِ وغيرها، بل يُمنع من الاشتراكِ فيها؛ لعدمِ اعتبارِها كوسيطٍ مقبولٍ للتبادلِ من الجهاتِ المخُتصَّةِ، ولِمَا تشتمل عليه من الضررِ الناشئ عن الغررِ والجهالةِ والغشِّ في مَصْرِفها ومِعْيارها وقِيمتها، فضلًا عما تؤدي إليه ممارستُها من مخاطرَ عاليةٍ على الأفراد والدول.Injective receives a Doubtful verdict primarily due to its revenue model and how that revenue structurally benefits token holders.According to research and opinion of experts so far, cryptocurrency is not considered ‘ maal ’ (wealth) in Sharia.Muhammadiyah memandang transaksi dan investasi kripto pada dasarnya mubah (boleh) tetapi dengan syarat tertentu.The opinion on this is the same as doing the same with any halal assets such as shares – 1) is permissible, 2) is more debatable and there are differing opinions on short-term trading.Our current position is 'tawaquf'; we can't say it is halal or haram, but we say it is better not to engage in itAs I mentioned at the beginning of this article it is not necessary to substantiate the permissibility of something as long as there are no prohibited factors involved in it or surrounding it.AI-assisted analysis checked against sources. Not a fatwa or investment advice.
Where it trades
No exchanges from our coverage trade Injective yet
Similar halal assets
Halal verdict, same category
